Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Rx Assistance Program Seeks To Reaffirm Rebates; Most Firms Re-Sign

Executive Summary

Maine is seeking to relaunch its Low Cost Drugs for the Elderly and Disabled Program (DEL) by renewing rebate pledges from manufacturers

You may also be interested in...



Maine low income Rx plan

Maine extends deadline until end of May for manufacturers to reaffirm rebates for Low Cost Drugs for the Elderly and Disabled Program (1"The Pink Sheet" May 5, p. 7). Maine Department of Human Services Acting Commissioner Peter Walsh plans to send a letter to the 85 companies that have not renewed prior agreements...

Maine low income Rx plan

Maine extends deadline until end of May for manufacturers to reaffirm rebates for Low Cost Drugs for the Elderly and Disabled Program (1"The Pink Sheet" May 5, p. 7). Maine Department of Human Services Acting Commissioner Peter Walsh plans to send a letter to the 85 companies that have not renewed prior agreements...

Washington State House Passes Preferred Drug List, Medicaid Rx Waiver Plan

Washington state's legislature is seeking to create a preferred drug list for state health care programs that would also be available to individuals and businesses

Related Content

UsernamePublicRestriction

Register

PS041738

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel